26 Jan 2026
18:00 CET |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
26 Jan 2026
18:00 CET |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
23 Jan 2026
18:00 CET |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
23 Jan 2026
18:00 CET |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
19 Jan 2026
18:00 CET |
OXURION |
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
|
20103010 Biotechnology |
Change in Capital |
19 Jan 2026
18:00 CET |
OXURION |
Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
|
20103010 Biotechnology |
Change in Capital |
19 Jan 2026
08:00 CET |
OXURION |
Oxurion annonce la suspension temporaire du programme de financement dédié à des investissements dans les actifs numériques et crypto-actifs
|
20103010 Biotechnology |
Legal |
19 Jan 2026
08:00 CET |
OXURION |
Oxurion announces the temporary suspension of the financing programme dedicated to investments in digital assets and crypto-assets
|
20103010 Biotechnology |
Legal |
13 Jan 2026
18:00 CET |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
13 Jan 2026
18:00 CET |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
17 Dec 2025
18:00 CET |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
17 Dec 2025
18:00 CET |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
01 Dec 2025
08:00 CET |
OXURION |
Oxurion secures a binding EUR 30 million financing facility dedicated to investments in digital and crypto assets
|
20103010 Biotechnology |
Legal |
01 Dec 2025
08:00 CET |
OXURION |
Oxurion sécurise un financement ferme de 30 millions d'euros dédié à des investissements dans les actifs numériques et crypto actifs
|
20103010 Biotechnology |
Legal |
25 Nov 2025
18:00 CET |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
25 Nov 2025
18:00 CET |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
20 Nov 2025
18:00 CET |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
20 Nov 2025
18:00 CET |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
03 Nov 2025
18:00 CET |
OXURION |
Oxurion met fin aux discussions relatives à une transaction ciblée en préclinique annoncée précédemment et poursuit l'intégration d'un acteur clinique stratégique
|
20103010 Biotechnology |
Legal |
03 Nov 2025
18:00 CET |
OXURION |
Oxurion ends discussions regarding previously announced preclinical transaction and continues integration of a strategic clinical partner
|
20103010 Biotechnology |
Legal |
23 Oct 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
23 Oct 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
17 Oct 2025
18:00 CEST |
OXURION |
Oxurion Receives Amended Transparency Notifications from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
17 Oct 2025
18:00 CEST |
OXURION |
Oxurion ontvangt aangepaste transparantiekennisgevingen van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
16 Oct 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
16 Oct 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
15 Oct 2025
18:00 CEST |
OXURION |
Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
|
20103010 Biotechnology |
Change in Capital |
15 Oct 2025
18:00 CEST |
OXURION |
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
|
20103010 Biotechnology |
Change in Capital |
13 Oct 2025
18:30 CEST |
OXURION |
Oxurion signe une lettre d'intention pour l'acquisition projetée d'une CRO dotée d'une forte complémentarité avec Axiodis
|
20103010 Biotechnology |
Legal |
13 Oct 2025
18:30 CEST |
OXURION |
Oxurion signs letter of intent for the contemplated acquisition of a CRO with strong complementarity to Axiodis
|
20103010 Biotechnology |
Legal |
09 Oct 2025
18:00 CEST |
OXURION |
Oxurion annonce une mise à jour de sa stratégie d'investissement dans des actifs numériques
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquiqitions, Transferts |
09 Oct 2025
18:00 CEST |
OXURION |
Oxurion provides an update related to its investment strategy in digital assets
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquiqitions, Transferts |
03 Oct 2025
18:00 CEST |
OXURION |
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
|
20103010 Biotechnology |
Change in Capital |
03 Oct 2025
18:00 CEST |
OXURION |
Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
|
20103010 Biotechnology |
Change in Capital |
02 Oct 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
02 Oct 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
30 Sep 2025
18:00 CEST |
OXURION |
Oxurion publie ses résultats du premier semestre 2025
|
20103010 Biotechnology |
Sales, Income |
30 Sep 2025
18:00 CEST |
OXURION |
Oxurion Publishes First Half 2025 Results
|
20103010 Biotechnology |
Sales, Income |
16 Sep 2025
18:00 CEST |
OXURION |
Axiodis CRO, the French subsidiary of the Oxurion Group, announces a dual AI-driven strategic initiative to transform clinical trials
|
20103010 Biotechnology |
Legal |
16 Sep 2025
18:00 CEST |
OXURION |
Axiodis CRO, la filiale française du Groupe Oxurion annonce une double initiative stratégique autour de l'IA pour transformer les essais cliniques
|
20103010 Biotechnology |
Legal |
08 Sep 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
08 Sep 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
01 Sep 2025
18:00 CEST |
OXURION |
Oxurion confirme l'avancée des négociations relatives à sa stratégie de diversification de sa trésorerie ; un closing de l'opération est envisagé avant le 25 septembre 2025
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquiqitions, Transferts |
01 Sep 2025
18:00 CEST |
OXURION |
Oxurion confirms progress in negotiations related to its treasury diversification strategy; closing of the transaction expected before September 25, 2025
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquiqitions, Transferts |
01 Sep 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
01 Sep 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
07 Aug 2025
18:00 CEST |
OXURION |
Oxurion met fin à son programme de RD sur la dégénérescence maculaire géographique et se recentre sur ses nouvelles activités de CRO
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquiqitions, Transferts |
07 Aug 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notifications from UBS Group AG
|
20103010 Biotechnology |
Change in Capital |
07 Aug 2025
18:00 CEST |
OXURION |
Oxurion Ends RD Program in Geographic Atrophy and Refocuses on New CRO Activities
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquiqitions, Transferts |
07 Aug 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgevingen van UBS Group AG
|
20103010 Biotechnology |
Change in Capital |